Clinical trial
A Randomized Controlled Study Evaluating the Effect of MUCIPLIQ Versus Placebo on the Incidence of Radio-chemotherapy-induced Mucositis in Patients Suffering of Upper Aerodigestive Tract Carcinomas
NCT01840436 is registered in ClinicalTrials.gov with Organ, Tissue, Regeneration, Repair and Replacement as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Study Evaluating the Effect of MUCIPLIQ Versus Placebo on the Incidence of Radio-chemotherapy-induced Mucositis in Patients Suffering of Upper Aerodigestive Tract Carcinomas
- Lead sponsor
- Organ, Tissue, Regeneration, Repair and Replacement
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- January 31, 2015
- Enrollment
- 136 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
carcinoma in situ of upper respiratory tract, oral mucositis